🇺🇸 US Stock Screener ← Switch market ★ Elite Club ⚡ HerAI
$546.51
+29.80% 1Y
P/E29.80
52W High$546.51
52W Low$368.09
EPS (TTM)$18.34

Company Overview

CHE (CHE) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.

Why Investors Should Care

Strong Return on Equity

Generates a return on equity of 27.1%, reflecting efficient use of shareholder capital.

Healthy Capital Returns

Return on capital employed stands at 27.0%.

Positive Free Cash Flow

Generates positive free cash flow, funding growth and shareholder returns internally.

Recent Developments

  • Dec 2025 Revenue of $2.53B (+65.3% YoY); net profit $265.24M.
  • Trailing 12 Months Year-on-year growth — revenue +65.2%, earnings -12.2%.
  • 5-Year Trend Long-term compounding — revenue CAGR 4.8%, profit CAGR 8.4%.

Growth & Price Performance

Compounded Sales Growth

5 Years:4.75%
1 Year:65.25%

Compounded Profit Growth

5 Years:8.40%
1 Year:-12.17%

Stock Price Performance

1 Year:+29.80%
6 Months:+26.51%
3 Months:+28.00%
1 Month:+12.60%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bullish
52-Week Range 100% of range
$368.09 $546.51
Trend Signals
  • Price vs 50-DMAAbove
  • Price vs 200-DMAAbove
  • RSI (14)76.75 · Overbought
Price Performance
1M+12.60%
3M+28.00%
6M+26.51%
1Y+29.80%

Auto-generated from price history and fundamentals; not investment advice.

Ad space

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

  • Strong return on equity of 27.1%.
  • Healthy ROCE of 27.0%.
  • Generates positive free cash flow.
  • In a confirmed uptrend (50-DMA above 200-DMA).

CONS

  • RSI at 77 suggests overbought conditions.

* The pros and cons are auto-generated from financial metrics.

Ad space

Valuation

Stock P/E
29.80
Industry PE
-
Forward P/E est.
33.93
PEG Ratio
-
Book Value
$-
Price to Book
-
P/S
-
EV/EBITDA
-
Dividend Yield
0.00%

Growth (CAGR)

Revenue 5Y
4.75%
Profit 5Y
8.40%
Revenue (YoY)
65.25%
Earnings (YoY)
-12.17%

Profitability & Returns

ROCE
27.04%
ROE
27.08%
ROA
17.24%
Profit Margin
10.48%
Op Margin
13.37%
Gross Margin
-
EPS (Latest Qtr)
$5.13
EPS (TTM)
$18.34

Balance Sheet & Liquidity

Debt/Equity
-
Quick Ratio
-
Current Ratio
-
Debt
-
Total Assets
$1.58B
Current Assets
-
Working Capital
-

Ownership

Promoter Holding
2.09%
Chg in Prom Hold
-
FII / Inst Holding
105.85%
Chg in FII Hold
-

Financial Snapshot

Enterprise Value
-
Total Revenue (TTM)
$2.53B
EBITDA
-
Free Cash Flow
$325.48M
Operating Cash Flow
$388.27M
Shares Outstanding
-
Gross Margin
-
Payout Ratio
-
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric Jun 2013Sep 2013Mar 2014Jun 2014Sep 2014Mar 2015Jun 2015Sep 2015Mar 2016Jun 2016Sep 2016Mar 2017Jun 2017Sep 2017Mar 2018Jun 2018Sep 2018Mar 2019Jun 2019Sep 2019Mar 2020Jun 2020Sep 2020Mar 2021Jun 2021Sep 2021Mar 2022Jun 2022Sep 2022Mar 2023Jun 2023Sep 2023Mar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025Mar 2026Jun 2026
Revenue -----------------------315.79M311.94M317.41M299.19M297.78M296.54M310.48M320.86M333.73M354.01M374.56M391.41M-----
Operating Income 25.89M29.21M36.65M41.52M40.21M40.57M44.60M50.13M44.39M38.36M42.87M41.45M-38.95M54.00M56.40M58.14M61.71M49.47M65.53M64.93M79.36M92.76M74.31M80.44M71.70M92.87M89.37M91.94M80.86M72.82M69.51M86.85M72.33M88.12M92.16M94.76M68.08M74.75M84.58M89.20M
Net Income 14.61M17.43M20.57M24.36M24.59M24.54M26.98M28.83M24.84M24.89M26.83M29.84M-21.66M35.44M45.00M54.97M51.25M44.67M50.73M58.95M55.89M82.10M67.72M65.40M56.52M72.00M64.17M66.46M56.87M54.12M53.38M74.96M65.02M70.89M75.78M71.76M52.49M64.24M66.30M67.70M
Diluted EPS 0.770.941.121.361.391.401.551.651.451.481.621.78-1.352.132.663.273.062.703.083.563.385.014.144.013.514.554.224.403.783.583.514.934.244.655.004.863.574.464.845.13

Profit & Loss (Annual)

Figures in USD.

Metric Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue 1.15B1.19B1.28B1.36B1.43B1.41B1.46B1.54B1.58B1.67B1.20B1.28B1.33B1.26B1.20B1.32B1.53B2.53B
Operating Income 132.86M126.34M143.52M153.73M156.42M133.39M168.42M184.46M178.75M113.03M243.63M257.38M389.68M343.04M343.50M340.57M366.49M338.25M
Net Income 67.28M73.78M81.83M85.98M89.30M77.23M99.32M110.27M108.74M98.18M205.54M219.92M319.47M268.55M249.62M272.51M302.00M265.24M
Diluted EPS 2.883.243.554.104.624.165.576.336.485.8612.2313.3119.4816.8516.5317.9319.8918.34

Balance Sheet (Annual)

Figures in USD.

Metric Dec 2007Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Total Assets --819.47M830.16M795.90M859.63M893.70M859.93M852.33M880.06M920.03M975.53M1.27B1.43B1.34B1.44B1.67B1.67B1.54B
Total Equity 395.80M396.83M477.16M462.05M413.68M453.29M448.89M451.36M513.25M524.10M540.35M591.33M726.61M901.20M623.27M798.72M1.11B1.12B979.40M
Cash & Equivalents 4.99M3.63M112.42M49.92M38.08M69.53M84.42M14.13M14.73M15.31M11.12M4.83M6.16M162.68M32.90M74.13M263.96M178.35M74.52M
Long Term Debt --152.13M159.21M166.78M174.89M183.56M141.25M83.75M100.00M91.20M89.20M90.00M-185.00M92.50M---
Total Liabilities --342.31M368.11M382.22M406.33M444.81M408.58M339.07M355.96M379.67M384.19M541.71M533.71M719.45M643.30M560.22M549.58M558.78M
Current Liabilities --136.08M149.34M145.40M156.82M363.99M175.55M171.34M171.83M193.52M191.67M262.22M299.11M302.40M297.20M312.05M285.69M287.13M

Cash Flows (Annual)

Figures in USD.

Metric Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating Cash Flow 112.08M160.83M86.01M174.34M131.77M--171.50M135.39M162.50M287.14M301.25M489.29M-309.89M330.30M417.50M388.27M
Investing Cash Flow -28.63M-22.84M-35.70M-34.11M-40.68M-31.35M--50.32M-39.86M-67.61M-105.22M-190.76M-61.56M--59.40M-60.64M-143.91M-59.34M
Financing Cash Flow -84.82M-29.20M-112.81M-152.06M-59.63M-104.61M--120.59M-94.95M-99.08M-188.20M-109.16M-271.21M--209.25M-79.83M-359.19M-432.77M
Capital Expenditure -26.09M-21.50M-25.64M-29.59M-35.25M-29.32M-43.57M-44.13M-39.77M-64.30M-52.87M-53.02M-58.83M--57.33M-56.85M-49.53M-62.80M
Free Cash Flow 85.99M139.34M60.37M144.75M96.52M--127.36M95.62M98.19M234.27M248.23M430.46M-252.56M273.44M367.97M325.48M
Net Change in Cash --------------41.23M189.83M-85.61M-103.83M
Share Buybacks 67.12M742.00K109.33M143.97M60.62M92.91M110.02M59.32M102.31M94.64M158.88M92.63M175.59M576.04M114.52M67.70M361.39M431.50M

Ratios (Annual)

Figures in %.

Metric Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Gross Margin % ------------------
Operating Margin % 11.6%10.6%11.2%11.3%10.9%9.4%11.6%12.0%11.3%6.8%20.3%20.1%29.2%27.2%28.6%25.9%23.9%13.4%
Net Margin % 5.9%6.2%6.4%6.3%6.2%5.5%6.8%7.1%6.9%5.9%17.2%17.2%23.9%21.3%20.8%20.7%19.7%10.5%
ROE % 17.0%15.5%17.7%20.8%19.7%17.2%22.0%21.5%20.7%18.2%34.8%30.3%35.4%43.1%31.3%24.6%27.0%27.1%
ROCE % -18.5%21.1%23.6%22.3%25.2%24.6%27.1%25.2%15.6%31.1%25.6%34.3%33.0%30.0%25.1%26.5%27.0%

Shareholding Pattern

Insiders
2.09%
Institutions
105.85%
Public Float
108.11%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for CHE

Google News Wed, 05 Aug 2026

Amundi Raises Stock Position in Chemed Corporation $CHE - MarketBeat

<a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxOUmdMcjNkajBuQmJ2X0tRWEdlUGRuQlI1aHBtYmZwRl9iaHBnMzZ4WVBIa0ROeWFsVmU1a2xobEx3SmhOMHlOWFdUZ3ZrdE0tcXc1S0oxdmwxVG5KTEZzWms2SGZrR0p0Q1RFN2RXRUZmZXFUZ1JLbFJNbUxtSXVSMW1pR0JmalNQRjVwSz…

Google News Wed, 05 Aug 2026

Trend Tracker for (CHE.DB.E) (CHE.DB.E:CA) - Stock Traders Daily

<a href="https://news.google.com/rss/articles/CBMiiwFBVV95cUxPWk5LSmtveE5aSVJjMkJhbnNWUkpHYkNnOTZDTXRTLWxXVmx1U3RJYWdmQTFha21ENy1YLUVvOS1NbnhmMUJKWTNzSG9Wa0x3Tl9JZUZ4MnNhVFdMRFVsbmJDa0VrMTdyY2JFRmNVS1hwVWt1LURaQ0hKODhWSkFhc3pUNDBuM085ejlR?o…

Google News Wed, 05 Aug 2026

Chemed Corporation: Why A Spin-Off Could Unlock Its Hidden Value (NYSE:CHE) - Seeking Alpha

<a href="https://news.google.com/rss/articles/CBMipwFBVV95cUxQaWFQUFNFS1pnUlBFRnZqaTQzWVJfMThLdkt2VGRxdUhDLW44RXZ1eHNEOE5Ga2kzZWdRcy05U1pkaE5mZ3RiM0NKaWFxZ1ZCN2UybmpmeDNwWmJyQ0RxNWxEV0FSMGh3aTlmTVkzRllOSmk5bm5FYzBsSkFsZ1RXaE1IbFZJMExVUVlLeS…

Google News Wed, 05 Aug 2026

Have Insiders Sold Chemed Shares Recently? - simplywall.st

<a href="https://news.google.com/rss/articles/CBMirgFBVV95cUxNX2JZQ2JLWEtfWGgzSHJETjVaeUJFV3JNT1VGUE1HNHVWZVNRM1o3aGlNVi1QQ3dPbGNvN0VEV2VCbkJGT054UXJPcVdJSy0zbzRwLVFCZm5VcXVUVjI4Tm1WZXBzcjNNYkptX3g3dWM4SW4zNXg2UFdkM3Y4cjR5QnhjZTRIT05IalpPSX…

Google News Mon, 03 Aug 2026

Chemed (NYSE: CHE) director sells 190 shares at $532 in open trade - Stock Titan

<a href="https://news.google.com/rss/articles/CBMipwFBVV95cUxOSTJ5dDluXzNSMEU2OG5HLWJuTGd6YTdJR18wUWRoVE9pSlJRNVFOejdwRzVPRFpWVjJVNzBDS0VfY21lNHFPd01pLTRWTUpaSVlyVWhpUFNYNmtvWUV6WUE3dGtXSjNteFVhNUtnRFBKQ1ZCanNkRzV2ZUEwbF9DVHcwbW85TWdUakNOek…

Google News hu, 30 Jul 2026

Chemed (CHE) Deepens Buybacks as Activist Pressure Mounts – What Does This Say About Strategy? - Yahoo Finance

<a href="https://news.google.com/rss/articles/CBMiowFBVV95cUxOWFltaGdYajUySUE3SWx3eEdEMW4xZGQ2RmhJdU54STNNbUZ3d2t0MGowWnBZUkNTQWxLZW1MU3Via0dSdUZtWUUwT19IRjdNemw0S25mbWhqRnZWM2ZQZzRqX3EzYzl5UVBlX2hXeFY1MmRJS2FFVjlWcjdYTThOb0pIcG9KekxQUnRWOF…

CHE — Frequently Asked Questions

What is the current share price of CHE?

As of 2026-08-05 17:25 PDT, CHE trades at $546.51 on NASDAQ/NYSE. Its 52-week range is $368.09 to $546.51.

What is the P/E ratio of CHE?

CHE trades at a trailing price-to-earnings (P/E) ratio of 29.80.

What is the return on equity (ROE) of CHE?

CHE has a return on equity (ROE) of 27.08%. Its return on capital employed (ROCE) is 27.04%.

Is CHE a good stock to buy?

This page provides a data-driven analysis of CHE, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks